Loading…
Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia
[Display omitted] •Minoxidil and latanoprost are compatible, which enabled their association.•The drugs combination’s bioactivity was encouraging, especially when nanoencapsulated.•The nanostructured system did not induce adverse outcomes in the skin.•Nanocarriers targeted 50% of both drugs delivery...
Saved in:
Published in: | European journal of pharmaceutics and biopharmaceutics 2022-03, Vol.172, p.78-88 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3 |
container_end_page | 88 |
container_issue | |
container_start_page | 78 |
container_title | European journal of pharmaceutics and biopharmaceutics |
container_volume | 172 |
creator | Oliveira, Paula M. Alencar-Silva, Thuany Pires, Felipe Q. Cunha-Filho, Marcilio Gratieri, Tais Carvalho, Juliana Lott Gelfuso, Guilherme M. |
description | [Display omitted]
•Minoxidil and latanoprost are compatible, which enabled their association.•The drugs combination’s bioactivity was encouraging, especially when nanoencapsulated.•The nanostructured system did not induce adverse outcomes in the skin.•Nanocarriers targeted 50% of both drugs delivery to the hair follicles.
Alopecia is a condition associated with different etiologies, ranging from hormonal changes to chemotherapy, that affects over 80 million people in the USA. Nevertheless, there are currently few FDA-approved drugs for topical treatment, and existing formulations still present skin irritation issues, compromising treatment adherence. This work aimed to develop a safe formulation based on nanostructured lipid carriers (NLC) that entrap an association of minoxidil and latanoprost and target drug delivery to the hair follicles. To do so, thermal techniques combined with FTIR were used to assess the chemical compatibility of the proposed drug association. Then, NLC with 393.5 ± 36.0 nm (PdI |
doi_str_mv | 10.1016/j.ejpb.2022.02.003 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2628301778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641122000248</els_id><sourcerecordid>2628301778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3</originalsourceid><addsrcrecordid>eNp9kE2LFDEQhoMo7rj6BzxIjl56rKT6E7zI4sfCohc9h-qk2s3Q02mTtLoXf7sZZvW4UBBI3vch9QjxUsFegWrfHPZ8WMe9Bq33UAbwkdipvsMK61o9FjsYcKjaWqkL8SylAwDUXdM_FRfYqBqHTu_En8-0hJTjZvMW2cnZr95JSzF6jknOgVy5_eXzraRFUkrBeso-LDJM8uiX8Ns7P5e3UqVcWGssODmFKDPF75xLO4fVW5plvuVI692pSXNYuZCeiycTzYlf3J-X4tuH91-vPlU3Xz5eX727qSw2ba5GDe04OGw0DkiMQK2jfux0g1rDhL1D7mHQrLmxjVKa2rpkoCbVjQ1bvBSvz9zyvR8bp2yOPlmeZ1o4bMnoVvcIquv6EtXnqC2bpMiTWaM_UrwzCszJuzmYk3dz8m6gDGApvbrnb-OR3f_KP9El8PYc4LLlz-LWJOt5sex8ZJuNC_4h_l_J5ZYB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628301778</pqid></control><display><type>article</type><title>Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia</title><source>ScienceDirect Journals</source><creator>Oliveira, Paula M. ; Alencar-Silva, Thuany ; Pires, Felipe Q. ; Cunha-Filho, Marcilio ; Gratieri, Tais ; Carvalho, Juliana Lott ; Gelfuso, Guilherme M.</creator><creatorcontrib>Oliveira, Paula M. ; Alencar-Silva, Thuany ; Pires, Felipe Q. ; Cunha-Filho, Marcilio ; Gratieri, Tais ; Carvalho, Juliana Lott ; Gelfuso, Guilherme M.</creatorcontrib><description>[Display omitted]
•Minoxidil and latanoprost are compatible, which enabled their association.•The drugs combination’s bioactivity was encouraging, especially when nanoencapsulated.•The nanostructured system did not induce adverse outcomes in the skin.•Nanocarriers targeted 50% of both drugs delivery to the hair follicles.
Alopecia is a condition associated with different etiologies, ranging from hormonal changes to chemotherapy, that affects over 80 million people in the USA. Nevertheless, there are currently few FDA-approved drugs for topical treatment, and existing formulations still present skin irritation issues, compromising treatment adherence. This work aimed to develop a safe formulation based on nanostructured lipid carriers (NLC) that entrap an association of minoxidil and latanoprost and target drug delivery to the hair follicles. To do so, thermal techniques combined with FTIR were used to assess the chemical compatibility of the proposed drug association. Then, NLC with 393.5 ± 36.0 nm (PdI < 0.4) and +22.5 ± 0.2 mV zeta potential were produced and shown to entrap 86.9% of minoxidil and 99.9% of latanoprost efficiently. In vitro, the free drug combination was indicated to exert positive effects over human primary epidermal keratinocytes, supporting cell proliferation, migration and inducing the mRNA expression of MKI67 proliferation marker and VEGF – a possible effector for minoxidil-mediated hair growth. Interestingly, such a favorable drug combination profile was optimized when delivered using our NLC. Furthermore, according to the HET-CAM and reconstructed human epidermis assays, the nanoformulation was well tolerated. Finally, drug penetration was evaluated in vitro using porcine skin. Such experiments indicated that the NLC could be deposited preferentially into the hair follicles, causing a considerable increase in the penetration of the two drugs in such structures, compared to the control (composed of the free compounds) and generating a target-effect of approximately 50% for both drugs. In summary, present results suggest that hair follicle-targeted delivery of the minoxidil and latanoprost combination is a promising alternative to treat alopecia.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2022.02.003</identifier><identifier>PMID: 35143972</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Alopecia ; Hair follicle ; Latanoprost ; Minoxidil ; Nanoparticle ; Skin</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2022-03, Vol.172, p.78-88</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3</citedby><cites>FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35143972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oliveira, Paula M.</creatorcontrib><creatorcontrib>Alencar-Silva, Thuany</creatorcontrib><creatorcontrib>Pires, Felipe Q.</creatorcontrib><creatorcontrib>Cunha-Filho, Marcilio</creatorcontrib><creatorcontrib>Gratieri, Tais</creatorcontrib><creatorcontrib>Carvalho, Juliana Lott</creatorcontrib><creatorcontrib>Gelfuso, Guilherme M.</creatorcontrib><title>Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>[Display omitted]
•Minoxidil and latanoprost are compatible, which enabled their association.•The drugs combination’s bioactivity was encouraging, especially when nanoencapsulated.•The nanostructured system did not induce adverse outcomes in the skin.•Nanocarriers targeted 50% of both drugs delivery to the hair follicles.
Alopecia is a condition associated with different etiologies, ranging from hormonal changes to chemotherapy, that affects over 80 million people in the USA. Nevertheless, there are currently few FDA-approved drugs for topical treatment, and existing formulations still present skin irritation issues, compromising treatment adherence. This work aimed to develop a safe formulation based on nanostructured lipid carriers (NLC) that entrap an association of minoxidil and latanoprost and target drug delivery to the hair follicles. To do so, thermal techniques combined with FTIR were used to assess the chemical compatibility of the proposed drug association. Then, NLC with 393.5 ± 36.0 nm (PdI < 0.4) and +22.5 ± 0.2 mV zeta potential were produced and shown to entrap 86.9% of minoxidil and 99.9% of latanoprost efficiently. In vitro, the free drug combination was indicated to exert positive effects over human primary epidermal keratinocytes, supporting cell proliferation, migration and inducing the mRNA expression of MKI67 proliferation marker and VEGF – a possible effector for minoxidil-mediated hair growth. Interestingly, such a favorable drug combination profile was optimized when delivered using our NLC. Furthermore, according to the HET-CAM and reconstructed human epidermis assays, the nanoformulation was well tolerated. Finally, drug penetration was evaluated in vitro using porcine skin. Such experiments indicated that the NLC could be deposited preferentially into the hair follicles, causing a considerable increase in the penetration of the two drugs in such structures, compared to the control (composed of the free compounds) and generating a target-effect of approximately 50% for both drugs. In summary, present results suggest that hair follicle-targeted delivery of the minoxidil and latanoprost combination is a promising alternative to treat alopecia.</description><subject>Alopecia</subject><subject>Hair follicle</subject><subject>Latanoprost</subject><subject>Minoxidil</subject><subject>Nanoparticle</subject><subject>Skin</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE2LFDEQhoMo7rj6BzxIjl56rKT6E7zI4sfCohc9h-qk2s3Q02mTtLoXf7sZZvW4UBBI3vch9QjxUsFegWrfHPZ8WMe9Bq33UAbwkdipvsMK61o9FjsYcKjaWqkL8SylAwDUXdM_FRfYqBqHTu_En8-0hJTjZvMW2cnZr95JSzF6jknOgVy5_eXzraRFUkrBeso-LDJM8uiX8Ns7P5e3UqVcWGssODmFKDPF75xLO4fVW5plvuVI692pSXNYuZCeiycTzYlf3J-X4tuH91-vPlU3Xz5eX727qSw2ba5GDe04OGw0DkiMQK2jfux0g1rDhL1D7mHQrLmxjVKa2rpkoCbVjQ1bvBSvz9zyvR8bp2yOPlmeZ1o4bMnoVvcIquv6EtXnqC2bpMiTWaM_UrwzCszJuzmYk3dz8m6gDGApvbrnb-OR3f_KP9El8PYc4LLlz-LWJOt5sex8ZJuNC_4h_l_J5ZYB</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Oliveira, Paula M.</creator><creator>Alencar-Silva, Thuany</creator><creator>Pires, Felipe Q.</creator><creator>Cunha-Filho, Marcilio</creator><creator>Gratieri, Tais</creator><creator>Carvalho, Juliana Lott</creator><creator>Gelfuso, Guilherme M.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202203</creationdate><title>Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia</title><author>Oliveira, Paula M. ; Alencar-Silva, Thuany ; Pires, Felipe Q. ; Cunha-Filho, Marcilio ; Gratieri, Tais ; Carvalho, Juliana Lott ; Gelfuso, Guilherme M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alopecia</topic><topic>Hair follicle</topic><topic>Latanoprost</topic><topic>Minoxidil</topic><topic>Nanoparticle</topic><topic>Skin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oliveira, Paula M.</creatorcontrib><creatorcontrib>Alencar-Silva, Thuany</creatorcontrib><creatorcontrib>Pires, Felipe Q.</creatorcontrib><creatorcontrib>Cunha-Filho, Marcilio</creatorcontrib><creatorcontrib>Gratieri, Tais</creatorcontrib><creatorcontrib>Carvalho, Juliana Lott</creatorcontrib><creatorcontrib>Gelfuso, Guilherme M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oliveira, Paula M.</au><au>Alencar-Silva, Thuany</au><au>Pires, Felipe Q.</au><au>Cunha-Filho, Marcilio</au><au>Gratieri, Tais</au><au>Carvalho, Juliana Lott</au><au>Gelfuso, Guilherme M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2022-03</date><risdate>2022</risdate><volume>172</volume><spage>78</spage><epage>88</epage><pages>78-88</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>[Display omitted]
•Minoxidil and latanoprost are compatible, which enabled their association.•The drugs combination’s bioactivity was encouraging, especially when nanoencapsulated.•The nanostructured system did not induce adverse outcomes in the skin.•Nanocarriers targeted 50% of both drugs delivery to the hair follicles.
Alopecia is a condition associated with different etiologies, ranging from hormonal changes to chemotherapy, that affects over 80 million people in the USA. Nevertheless, there are currently few FDA-approved drugs for topical treatment, and existing formulations still present skin irritation issues, compromising treatment adherence. This work aimed to develop a safe formulation based on nanostructured lipid carriers (NLC) that entrap an association of minoxidil and latanoprost and target drug delivery to the hair follicles. To do so, thermal techniques combined with FTIR were used to assess the chemical compatibility of the proposed drug association. Then, NLC with 393.5 ± 36.0 nm (PdI < 0.4) and +22.5 ± 0.2 mV zeta potential were produced and shown to entrap 86.9% of minoxidil and 99.9% of latanoprost efficiently. In vitro, the free drug combination was indicated to exert positive effects over human primary epidermal keratinocytes, supporting cell proliferation, migration and inducing the mRNA expression of MKI67 proliferation marker and VEGF – a possible effector for minoxidil-mediated hair growth. Interestingly, such a favorable drug combination profile was optimized when delivered using our NLC. Furthermore, according to the HET-CAM and reconstructed human epidermis assays, the nanoformulation was well tolerated. Finally, drug penetration was evaluated in vitro using porcine skin. Such experiments indicated that the NLC could be deposited preferentially into the hair follicles, causing a considerable increase in the penetration of the two drugs in such structures, compared to the control (composed of the free compounds) and generating a target-effect of approximately 50% for both drugs. In summary, present results suggest that hair follicle-targeted delivery of the minoxidil and latanoprost combination is a promising alternative to treat alopecia.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35143972</pmid><doi>10.1016/j.ejpb.2022.02.003</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0939-6411 |
ispartof | European journal of pharmaceutics and biopharmaceutics, 2022-03, Vol.172, p.78-88 |
issn | 0939-6411 1873-3441 |
language | eng |
recordid | cdi_proquest_miscellaneous_2628301778 |
source | ScienceDirect Journals |
subjects | Alopecia Hair follicle Latanoprost Minoxidil Nanoparticle Skin |
title | Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A17%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nanostructured%20lipid%20carriers%20loaded%20with%20an%20association%20of%20minoxidil%20and%20latanoprost%20for%20targeted%20topical%20therapy%20of%20alopecia&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Oliveira,%20Paula%20M.&rft.date=2022-03&rft.volume=172&rft.spage=78&rft.epage=88&rft.pages=78-88&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2022.02.003&rft_dat=%3Cproquest_cross%3E2628301778%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-b206b9d352393ae30a6da8b7253220f38d3e8092e2e5c5112a640a604a17b5ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2628301778&rft_id=info:pmid/35143972&rfr_iscdi=true |